News about our portfolio and insights from the vc world
Biped Gears up for Boston Investor Presentation
Venturelab has interviewed Maël Fabien, founder of our Serpentine Ventures portfolio company Biped. As part of the Swiss National Medtech Team 2023, Biped is set to unveil its revolutionary AI copilot innovation to investors in Boston.
Three Serpentine Ventures Portfolio Companies Featured in TOP 100 Swiss Startups
Our Serpentine Ventures portfolio companies, Properti AG, Isochronic AG and Auxivo AG were recognized as being part of the TOP 100 Swiss Startup Awards 2023. Congratulations and we remain committed to supporting their continued success.
Piomic Medical Announces First Patients Enrolled in MAVERICKS Study Sites
Piomic, our Swiss Diabetes Venture Fund portfolio company, enrolls first patients in MAVERICKS U.S. study after Medicare Category B designation. FDA-approved IDE study sets groundwork for device authorization and commercialization.
Private Markets - Shaping the Future of Finance
Discover the insights in Partners Group's white paper: Private Markets - The New Traditional Asset Class. Explore how private and public markets are redefining the role of financing in the real economy.
Upcoming Venture Asset Management Program
Our Venture Asset Management Program with IMD is happening next week on Aug 31 - Sep 1. Two days of deep learning and fully booked with enthusiastic participants, reflecting our commitment to shaping the future of Venture Asset Management.
AI puts to rest a decades-long debate about the origins of this painting, now identified a Renaissance masterpiece.
While disputed by scholars, a painting attributed by AI to Renaissance master Raphael has been showcased at a gallery in the UK. This development highlights a growing acceptance of AI as a tool for authentication within the art community.